MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-27-0003912
Medigraph Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹25.9 Cr
▼ 12% YoY
Net profit · FY 2025
₹1.91 Cr
Net margin 7.4%
EBITDA · FY 2025
₹3.22 Cr
EBITDA margin 12.4%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹24 Lakh
Issued & subscribed
Open charges
₹2.31 Cr
Satisfied ₹2.5 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
2
Provident fund records
About Medigraph Pharmaceuticals Private Limited
Data last updated:
Medigraph Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 10 March 1995 and has been in existence for over 31 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1995PTC086316. Its GSTIN is 27AAACM8346C1ZL (Maharashtra).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹24 Lakh. It is led by directors Pranay Ramniwas Goel and Pankaj Ravindra Chaudhari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹25.9 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹1.91 Cr (net margin 7.4%) and EBITDA of ₹3.22 Cr (EBITDA margin 12.4%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years and 15% over five years.
The company has about 2 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: PharmaCompass and Sanvin. As per MCA filings, the company has open charges of ₹2.31 Cr and satisfied charges of ₹2.5 Cr on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
Medigraph Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-27-0003912). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website sanvin.co.in.
Company details
CIN U24239MH1995PTC086316
Registration Number 086316
Incorporation Date 10 March 1995
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-MH-27-0003912
Recognitions & Rankings of Medigraph Pharmaceuticals
Contact details
Medigraph Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra. Its website is sanvin.co.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address301 Malhotra Chambers, Plot No 275A – 1/2 Off Govandi Stn Rd Deonar, Mumbai, Maharashtra, India – 400088
- IndustryPharma, API Manufacturers
To see the full contact details of Medigraph Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Medigraph Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Medigraph Pharmaceuticals operates two associated brands: PharmaCompass and SANVIN. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers API, FDF, excipients sourcing and market intelligence for pharmaceutical businesses worldwide. | pharmacompass.com | |
| Pharmaceutical and intermediate manufacturing operations near Mumbai. | sanvin.co.in |
Business activity
The main business activity of Medigraph Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medigraph Pharmaceuticals Private Limited, buy the company report.
Financials of Medigraph Pharmaceuticals Private Limited
FY 2025 filings availableMedigraph Pharmaceuticals Private Limited reported revenue of ₹25.9 Cr (down 12% YoY) for FY 2025.
Revenue · FY 2025
₹25.9 Cr ▼ 12%
Net profit · FY 2025
₹1.91 Cr margin 7.4%
EBITDA · FY 2025
₹3.22 Cr margin 12.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 5%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▼ 46%
3 years · compounded
▼ 28%
5 years · compounded
▲ 38%
Revenue fell 12% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 15%. EBITDA fell 46% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹3.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.91 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.4% | ||||
| Net Profit Margin | 7.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medigraph Pharmaceuticals Private Limited, buy the company report.
Board of directors of Medigraph Pharmaceuticals Private Limited
Medigraph Pharmaceuticals has 2 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pranay Ramniwas Goel | Director | 10 Mar 1995 | 31 Years 7 Months | Current |
| Pankaj Ravindra Chaudhari Also directs: Marma Sutra LLP | Director | 08 Dec 2012 | 13 Years 10 Months | Current |
Peer comparison
Medigraph Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Enam Organics India Limited | ₹26.08 Cr (FY 2025) | 19.0% | Thane, Maharashtra, India | |||
| Vaikunth Chemicals Pvt Ltd | ₹25.98 Cr (FY 2025) | 20.0% | Ankleswar, Gujarat, India | |||
| Surge Pharmaceuticals Private Limited | ₹25.94 Cr (FY 2024) | 0.0% | Vadodara, Gujarat, India | |||
| Medigraph Pharmaceuticals Private Limitedthis company | ₹25.9 Cr (FY 2025) | ₹1.91 Cr | 7.4% | -12.0% | 2 | Mumbai, Maharashtra, India |
| Bhugan Lifescience Private Limited | ₹25.74 Cr (FY 2025) | 30.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Medigraph Pharmaceuticals Private Limited, buy the company report.
Auditor
Medigraph Pharmaceuticals Private Limited is audited by Damji Merchant & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Damji Merchant & Co | FY 2023 | 102082W |
Shareholding
The shareholding of Medigraph Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medigraph Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹2.31 Cr
Satisfied charges
₹2.5 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 28 Feb 2024 | 100912435 | Hdfc Bank Limited | ₹30.75 Lakh | Open | |
| 03 Dec 2022 | 100661065 | Hdfc Bank Limited | ₹2 Cr | Open | |
| 07 Nov 2020 | 100419990 | Hdfc Bank Limited | ₹2.5 Cr | Satisfied |
To see the full charge records of Medigraph Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Medigraph Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed.
Total cases
2
Filed against the company
2
Pending
1
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Maharashtra Industrial and Lab, Maharashtra | Court case (Appln.PGA) | Filed against the company by an individual | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrant cases SW) | Filed against the company by an individual | Disposed |
To see the full case history of Medigraph Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medigraph Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Medigraph Pharmaceuticals Private Limited has a workforce of 2 employees on its EPFO records as of Oct 11, 2024, across 1 active EPFO establishment.
Employee count
2
Active EPFO establishments
1
Employee growth
-33.33%
GST
Medigraph Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACM8346C1ZL | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medigraph Pharmaceuticals Private Limited, buy the company report.
Recent activity
Medigraph Pharmaceuticals Private Limited has 6 board changes on record since 1995: 2 appointments and 4 cessations. The latest: Srivathsan Krishamur Iyer ceased to be Director on 03 Oct 2014.
AGM
Medigraph Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medigraph Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge with Hdfc Bank Limited of Rs. 200.00 Lakh registered on 03 Dec 2022 with Charge ID 100661065 was modified on 11 Jun 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 30.75 Lakh with Charge ID 100912435 was registered on 28 Feb 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 200.00 Lakh with Charge ID 100661065 was registered on 03 Dec 2022.
Charges
A charge registered on 07 Nov 2020 via Charge ID 100419990 with Hdfc Bank Limited was fully satisfied on 02 Aug 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 250.00 Lakh with Charge ID 100419990 was registered on 07 Nov 2020.
Ceased
Srivathsan Krishamur Iyer ceased to be Director.
Ceased
Rajan Dansingh Nagarkoti ceased to be Director.
Appointed
Pankaj Ravindra Chaudhari was appointed as Director.
Ceased
Shankar Narayan Iyer ceased to be Director.
Ceased
Manohar Ramchandra Mulye ceased to be Director.
2 earlier events are in the company report.
Frequently asked questions
Medigraph Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 10 March 1995 (31+ years old) and is registered under CIN U24239MH1995PTC086316.
Medigraph Pharmaceuticals has 2 current directors:
- Pranay Ramniwas Goel - Director
- Pankaj Ravindra Chaudhari - Director
The latest financial statements of Medigraph Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Medigraph Pharmaceuticals is 27AAACM8346C1ZL, registered in Maharashtra.
The CIN (Corporate Identification Number) of Medigraph Pharmaceuticals is U24239MH1995PTC086316. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medigraph Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending.
Medigraph Pharmaceuticals was incorporated on 10 March 1995, making it 31+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medigraph Pharmaceuticals by revenue are Enam Organics India Limited, Vaikunth Chemicals Pvt Ltd, Surge Pharmaceuticals Private Limited, Bhugan Lifescience Private Limited, all in the Pharma industry (API Manufacturers, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Srivathsan Krishamur Iyer ceased to be Director on 03 Oct 2014. Rajan Dansingh Nagarkoti ceased to be Director on 01 Oct 2013. Pankaj Ravindra Chaudhari was appointed as Director on 08 Dec 2012. Medigraph Pharmaceuticals has 6 board changes on record in total.
Yes, Medigraph Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-MH-27-0003912).
Medigraph Pharmaceuticals can be reached through the website sanvin.co.in. Its registered office is in Mumbai, Maharashtra, India.